Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Others), By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027

The Global Gynecology Drugs Market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the Global Gynecology Drugs Market in the forecast period.

The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the Global Gynecology Drugs Market in the forecast period.

The Global Gynecology Drugs Market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.

Major companies operating in the Global Gynecology Drugs Market are Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.

Years considered for this report:

Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027

Objective of the Study:

To analyze the historical growth and the market size of the Global Gynecology Drugs Market from 2017 to 2021.
To estimate and forecast the market size of the Global Gynecology Drugs Market from 2023 to 2027 and growth rate until 2027.
To classify and forecast the Global Gynecology Drugs Market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
To identify drivers and challenges for the Global Gynecology Drugs Market.
To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the Global Gynecology Drugs Market.
To conduct pricing analysis for the Global Gynecology Drugs Market.
To identify and analyze the profile of leading players operating in the Global Gynecology Drugs Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. The publisher Research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the Global Gynecology Drugs Market all over the world.

The publisher calculated the Global Gynecology Drugs Market size by using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. The publisher Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

Gynecology drugs manufacturers/suppliers/distributors
Government bodies such as regulating authorities and policy makers
Organizations, forums, and alliances related to gynecology drugs
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.

Report Scope:

In this report, the Global Gynecology Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Gynecology Drugs Market, By Therapeutics:

Non-Hormonal Therapy
Hormonal Therapy

Gynecology Drugs Market, By Indication:

Contraception
Gynecology Infections
Female Infertility
Postmenopausal disorders
Polycystic Ovary Syndrome
Osteoporosis
Gynecology Cancers
Endometriosis
Others (Urogenital Malformation, UTI & others)

Gynecology Drugs Market, By Distribution Channel:

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Gynecology Drugs Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gynecology Drugs Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:

What is the estimated value of the Global Gynecology Drugs Market?

The Global Gynecology Drugs Market was estimated to be valued at $11581.23 Million in 2017.

What is the growth rate of the Global Gynecology Drugs Market?

The growth rate of the Global Gynecology Drugs Market is 6.3%, with an estimated value of $21395.67 Million by 2027.

What is the forecasted size of the Global Gynecology Drugs Market?

The Global Gynecology Drugs Market is estimated to be worth $21395.67 Million by 2027.

Who are the key companies in the Global Gynecology Drugs Market?

Key companies in the Global Gynecology Drugs Market include Eli Lilly and Company Ltd., Pfizer Inc., Merck & Co., Inc., Amgen Inc., AstraZeneca Plc, F. Hoffmann, La Roche Ltd., Allergan Plc., Bayer AG and Abbott Laboratories Ltd..

Report Attribute	Details
No. of Pages	199
Published	July 2022
Forecast Period	2017 - 2027
Estimated Market Value ( USD ) in 2017	$ 11581.23 Million
Forecasted Market Value ( USD ) by 2027	$ 21395.67 Million
Compound Annual Growth Rate	6.3%
Regions Covered	Global

1. Product Overview2. Research Methodology3. Executive Summary

4. Voice of Customer

4.1. Brand Awareness
4.2. Factors Affecting Purchase Decision
4.3. Product Preference, By Therapeutics

5. Impact of COVID-19 on Global Gynecology Drugs Market

6. Global Gynecology Drugs Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
6.2.2. By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others)
6.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
6.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.5. By Company (2021)
6.3. Product Market Map

7. North America Gynecology Drugs Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutics
7.2.2. By Indication
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Gynecology Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutics
7.3.1.2.2. By Indication
7.3.1.2.3. By Distribution Channel
7.3.2. Canada Gynecology Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutics
7.3.2.2.2. By Indication
7.3.2.2.3. By Distribution Channel
7.3.3. Mexico Gynecology Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutics
7.3.3.2.2. By Indication
7.3.3.2.3. By Distribution Channel

8. Europe Gynecology Drugs Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutics
8.2.2. By Indication
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Gynecology Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutics
8.3.1.2.2. By Indication
8.3.1.2.3. By Distribution Channel
8.3.2. France Gynecology Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutics
8.3.2.2.2. By Indication
8.3.2.2.3. By Distribution Channel
8.3.3. United Kingdom Gynecology Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutics
8.3.3.2.2. By Indication
8.3.3.2.3. By Distribution Channel
8.3.4. Italy Gynecology Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutics
8.3.4.2.2. By Indication
8.3.4.2.3. By Distribution Channel
8.3.5. Spain Gynecology Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutics
8.3.5.2.2. By Indication
8.3.5.2.3. By Distribution Channel

9. Asia Pacific Gynecology Drugs Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutics
9.2.2. By Indication
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Gynecology Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutics
9.3.1.2.2. By Indication
9.3.1.2.3. By Distribution Channel
9.3.2. Japan Gynecology Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutics
9.3.2.2.2. By Indication
9.3.2.2.3. By Distribution Channel
9.3.3. India Gynecology Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutics
9.3.3.2.2. By Indication
9.3.3.2.3. By Distribution Channel
9.3.4. Australia Gynecology Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapeutics
9.3.4.2.2. By Indication
9.3.4.2.3. By Distribution Channel
9.3.5. South Korea Gynecology Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapeutics
9.3.5.2.2. By Indication
9.3.5.2.3. By Distribution Channel

10. South America Gynecology Drugs Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutics
10.2.2. By Indication
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gynecology Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutics
10.3.1.2.2. By Indication
10.3.1.2.3. By Distribution Channel
10.3.2. Argentina Gynecology Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutics
10.3.2.2.2. By Indication
10.3.2.2.3. By Distribution Channel
10.3.3. Colombia Gynecology Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutics
10.3.3.2.2. By Indication
10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Gynecology Drugs Market Outlook

11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapeutics
11.2.2. By Indication
11.2.3. By Distribution Channel
11.2.4. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Gynecology Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapeutics
11.3.1.2.2. By Indication
11.3.1.2.3. By Distribution Channel
11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapeutics
11.3.2.2.2. By Indication
11.3.2.2.3. By Distribution Channel
11.3.3. UAE Gynecology Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapeutics
11.3.3.2.2. By Indication
11.3.3.2.3. By Distribution Channel

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

14.1. Company profiles
14.1.1. Eli Lilly and Company Ltd.
14.1.2. Pfizer Inc.
14.1.3. Merck & Co., Inc.
14.1.4. Amgen Inc.
14.1.5. AstraZeneca Plc
14.1.6. F. Hoffmann-La Roche Ltd.
14.1.7. Allergan Plc.
14.1.8. Bayer AG
14.1.9. Abbott Laboratories Ltd.
14.1.10. AbbVie Inc.
14.1.11. GlaxoSmithKline Plc
14.1.12. Novartis Ltd.
14.1.13. Lupin Pharmaceuticals, Inc.
14.1.14. Johnson and Johnson Inc.
14.1.15. Sanofi SA

15. Strategic Recommendations

List of Figures

Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 5: Global Gynecology Drugs Market Share, By Region, By Value, 2017-2027F
Figure 6: Global Gynecology Drugs Market Share, By Company, By Value, 2021
Figure 7: Global Gynecology Drugs Market Map, By Therapeutics, Market Size (USD Million) & Growth Rate (%), 2021
Figure 8: Global Gynecology Drugs Market Map, By Indication, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Gynecology Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Gynecology Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: North America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 12: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 13: North America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 14: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 15: North America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 16: United States Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 17: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 18: United States Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 19: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 20: Canada Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 21: Fertility Rate in Canada, 2005, 2010, 2015, 2020
Figure 22: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 23: Canada Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 24: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 25: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 26: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 27: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 28: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: Europe Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 30: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 31: Europe Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 32: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 33: Europe Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 34: Germany Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 35: Fertility Rate in Germany, 2005, 2010, 2015, 2020
Figure 36: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 37: Germany Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 38: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 39: France Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 40: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 41: France Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 42: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 43: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 44: Prevalence of Menopause Symptoms Experienced by Women at Work in United Kingdom, 2021
Figure 45: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 46: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 47: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 48: Italy Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 49: Fertility Rate in Italy, 2005, 2010, 2015, 2020
Figure 50: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 51: Italy Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 52: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 53: Spain Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 54: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 55: Spain Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 56: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 57: Asia Pacific Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 58: Asia Pacific Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 59: Asia Pacific Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 60: Asia Pacific Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 61: Asia Pacific Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 62: China Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 63: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 64: China Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 65: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 66: Japan Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 67: Estimated Share of Women in Japan Using any Contraceptive Method, 2005, 2010, 2015, 2020
Figure 68: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 69: Japan Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 70: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 71: India Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 72: Polycystic Ovary Syndrome Issues Among Women Across India, By Age Group, 2020
Figure 73: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 74: India Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 75: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 76: Australia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 77: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 78: Australia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 79: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 80: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 81: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 82: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 83: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 84: South America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 85: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 86: South America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 87: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 88: South America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 89: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 90: Fertility Rate in Brazil, 2005, 2010, 2015, 2020
Figure 91: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 92: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 93: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 94: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 95: Total Female Population of Argentina, by Age Group, 2020 (in Millions)
Figure 96: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 97: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 98: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 99: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 100: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 101: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 102: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 103: Middle East & Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 104: Middle East & Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 105: Middle East & Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 106: Middle East & Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 107: Middle East & Africa Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 108: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 109: Fertility Rate in South Africa, 2005, 2010, 2015, 2020
Figure 110: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 111: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 112: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 113: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 114: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 115: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 116: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 117: UAE Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 118: Total Female Population of UAE, by Age Group, 2020 (in Millions)
Figure 119: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 120: UAE Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 121: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F

List of Tables

Table 1: Infertility Statistics of United States
Table 2: Ovary Cancer Cases in Mexico, 2020
Table 3: Ovary Cancer Cases in France, 2020
Table 4: Ovary Cancer Cases in Spain, 2020
Table 5: Ovary Cancer Cases in China, 2020
Table 6: Cancer Statistics of Australia, 2020
Table 7: Ovary Cancer Cases in South Korea, 2020
Table 8: Ovary Cancer Cases in Colombia, 2020
Table 9: Cervix Uteri Cancer Cases in Saudi Arabia, 2020